Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2021
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
0
Like
Facebook
Tweet this
Print
Paul Hodgkins, PhD, MSc
Executive Director
Gilead Sciences
Disclosure:
Gilead Sciences
(Employee, Shareholder)
Poster(s):
459 - COVID-19 hospitalization and 30-day readmission: a cohort study of U.S. hospitals
536 - Clinical Outcomes of Hospitalized COVID-19 Patients Treated with Remdesivir- NEAT ID 909REM Study
